tradmap

RMD Earnings ResMed

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
$0 $5 $10 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
EPS
Revenue (annual)
$0 $3B $6B 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Revenue
Net income (annual)
$0 $762M $2B 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Net income

Quarterly results

Diluted EPS (quarterly)
$0 $1 $3 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26 Q4 '26
EPS
Revenue (quarterly)
$0 $732M $1B Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue
Net income (quarterly)
$0 $209M $418M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Net income

Reported EPS history

1–60 of 60
Q1 20272026-09-302.922026-10-3010-Q
Q4 2026 (derived)2026-06-302.642026-08-1310-K
FY 20262026-06-3010.432026-08-1310-K
Q3 20262026-03-312.742026-05-0110-Q
Q2 20262025-12-312.682026-01-3010-Q
Q1 20262025-09-302.372025-10-3110-Q
Q4 2025 (derived)2025-06-302.582025-08-0810-K
FY 20252025-06-309.512025-08-0810-K
Q3 20252025-03-312.482025-04-2410-Q
Q2 20252024-12-312.342025-01-3110-Q
Q1 20252024-09-302.112024-10-2510-Q
Q4 2024 (derived)2024-06-301.972024-08-0910-K
FY 20242024-06-306.922024-08-0910-K
Q3 20242024-03-312.042024-04-2610-Q
Q2 20242023-12-311.422024-01-2510-Q
Q1 20242023-09-301.492023-10-2710-Q
Q4 2023 (derived)2023-06-301.552023-08-1110-K
FY 20232023-06-306.092023-08-1110-K
Q3 20232023-03-311.582023-04-2810-Q
Q2 20232022-12-311.532023-01-2710-Q
Q1 20232022-09-301.432022-10-2810-Q
Q4 2022 (derived)2022-06-301.322022-08-1210-K
FY 20222022-06-305.302022-08-1210-K
Q3 20222022-03-311.222022-04-2910-Q
Q2 20222021-12-311.372022-01-2810-Q
Q1 20222021-09-301.392021-10-2910-Q
Q4 2021 (derived)2021-06-301.332021-08-1710-K
FY 20212021-06-303.242021-08-1710-K
Q3 20212021-03-31-0.542021-04-3010-Q
Q2 20212020-12-311.232021-01-2910-Q
Q1 20212020-09-301.222020-10-3010-Q
Q4 2020 (derived)2020-06-301.222020-08-1310-K
FY 20202020-06-304.272020-08-1310-K
Q3 20202020-03-311.122020-05-0110-Q
Q2 20202019-12-311.102020-01-3110-Q
Q1 20202019-09-300.832019-10-2510-Q
Q4 2019 (derived)2019-06-300.482019-08-0810-K
FY 20192019-06-302.802019-08-0810-K
Q3 20192019-03-310.732019-05-0310-Q
Q2 20192018-12-310.862019-02-0110-Q
Q1 20192018-09-300.732018-10-2610-Q
Q4 2018 (derived)2018-06-300.762018-08-1710-K
FY 20182018-06-302.192018-08-1710-K
Q3 20182018-03-310.762018-04-2710-Q
Q2 20182017-12-310.072018-01-2410-Q
Q1 20182017-09-300.602017-10-2710-Q
Q4 2017 (derived)2017-06-300.702017-08-0410-K
FY 20172017-06-302.402017-08-0410-K
Q3 20172017-03-310.622017-04-2810-Q
Q2 20172016-12-310.542017-01-2510-Q
Q1 20172016-09-300.542016-10-2810-Q
Q4 2016 (derived)2016-06-300.592016-08-0510-K
FY 20162016-06-302.492016-08-0510-K
Q3 20162016-03-310.642016-04-2910-Q
Q2 20162015-12-310.682016-01-2810-Q
Q1 20162015-09-300.582015-10-2710-Q
Q4 2015 (derived)2015-06-300.612015-08-0710-K
FY 20152015-06-302.472015-08-0710-K
Q3 20152015-03-310.642015-04-2910-Q
Q2 20152014-12-310.642015-01-3010-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.